Bio-Techne Rebrands Atlanta Biologicals Serum And Media As Part Of The R&D Systems Product Portfolio

MINNEAPOLIS, Jan. 7, 2020 /PRNewswire/ -- Bio-Techne Corporation TECH today announced that the Atlanta Biologicals portfolio of serum and media will be rebranded as R&D Systems. As part of the rebranding, the Atlanta Biologicals website will be retired and the entire serum and media portfolio, including product details and purchasing options, will be maintained through the R&D Systems website. Currently all serum and media products can be purchased through R&D Systems.

Dave Eansor, President of Bio-Techne's Protein Sciences Segment, commented, "We are excited to consolidate the Atlanta Biologicals portfolio within R&D Systems' extended offering of cell culture solutions. By rolling the Atlanta Biologicals brand into R&D Systems, researchers will benefit from ensured product quality, an expanded portfolio of culture regents and an experience that enables the purchase of media, serum, proteins, antibodies, and more from a single, trusted source."

More information on the rebranding and retirement of Atlanta Biologicals can be found at https://www.rndsystems.com/atlanta-biologicals-now-rd-systems

About Bio-Techne Corporation TECH

Contact: 

David Clair, Senior Director, Corporate Development



david.clair@bio-techne.com



612-656-4416 

 

Bio-Techne

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/bio-techne-rebrands-atlanta-biologicals-serum-and-media-as-part-of-the-rd-systems-product-portfolio-300979866.html

SOURCE Bio-Techne Corporation

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Press ReleasesCorporate ExpansionNew Products/Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!